Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Osmoregulation Performance and Kidney Transplant Outcome.

Mazloum M, Jouffroy J, Brazier F, Legendre C, Neuraz A, Garcelon N, Prié D, Anglicheau D, Bienaimé F.

J Am Soc Nephrol. 2019 Jul;30(7):1282-1293. doi: 10.1681/ASN.2018121269. Epub 2019 Jun 19.

PMID:
31217325
2.

Physiology of FGF23 and overview of genetic diseases associated with renal phosphate wasting.

Bacchetta J, Bardet C, Prié D.

Metabolism. 2019 Jan 19. pii: S0026-0495(19)30021-6. doi: 10.1016/j.metabol.2019.01.006. [Epub ahead of print] Review.

PMID:
30664852
3.

Effects of L-Carnitine on Mineral Metabolism in the Multicentre, Randomized, Double Blind, Placebo-Controlled CARNIDIAL Trial.

Mercadal L, Tezenas du Montcel S, Chonchol MB, Debure A, Depreneuf H, Servais A, Bassilios N, Assogba U, Allouache M, Prié D.

Am J Nephrol. 2018;48(5):349-356. doi: 10.1159/000494338. Epub 2018 Nov 8.

PMID:
30408788
4.

Hepatic Production of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease.

Bienaimé F, Ambolet A, Aussilhou B, Brazier F, Fouchard M, Viau A, Barre P, Tissier AM, Correas JM, Paradis V, Terzi F, Friedlander G, Knebelmann B, Joly D, Prié D.

J Clin Endocrinol Metab. 2018 Jun 1;103(6):2319-2328. doi: 10.1210/jc.2018-00123.

PMID:
29618028
5.

Iron Chelation Resulting in Renal Phosphate Wasting.

Cheddani L, Leblanc T, Silve C, Tabibzadeh N, Prié D, Haymann JP, Péraldi MN, Daudon M, Meria P, Letavernier E.

Kidney Int Rep. 2017 Jul 29;3(1):1-4. doi: 10.1016/j.ekir.2017.07.011. eCollection 2018 Jan. No abstract available.

6.

The Association Between Fibroblast Growth Factor 23 and Renal Transplantation Outcome Is Modified by Follow-up Duration and Glomerular Filtration Rate Assessment Method.

Bienaimé F, Dechartres A, Anglicheau D, Sabbah L, Montgermont P, Friedlander G, Ravaud P, Legendre C, Prié D.

Kidney Int Rep. 2017 May 18;2(5):881-892. doi: 10.1016/j.ekir.2017.05.007. eCollection 2017 Sep.

7.

Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD.

Liabeuf S, Ryckelynck JP, El Esper N, Ureña P, Combe C, Dussol B, Fouque D, Vanhille P, Frimat L, Thervet E, Mentaverri R, Prié D, Choukroun G; FRENCH Study collaborators.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1930-1940. doi: 10.2215/CJN.03030317. Epub 2017 Oct 26.

8.

Evaluation of a New Fully Automated Assay for Plasma Intact FGF23.

Souberbielle JC, Prié D, Piketty ML, Rothenbuhler A, Delanaye P, Chanson P, Cavalier E.

Calcif Tissue Int. 2017 Nov;101(5):510-518. doi: 10.1007/s00223-017-0307-y. Epub 2017 Jul 31.

PMID:
28761972
9.

Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target.

Kormann R, Jannot AS, Narjoz C, Ribeil JA, Manceau S, Delville M, Joste V, Prié D, Pouchot J, Thervet E, Courbebaisse M, Arlet JB.

Br J Haematol. 2017 Oct;179(2):323-335. doi: 10.1111/bjh.14842. Epub 2017 Jul 12.

PMID:
28699644
10.

High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference.

Piketty ML, Prie D, Sedel F, Bernard D, Hercend C, Chanson P, Souberbielle JC.

Clin Chem Lab Med. 2017 May 1;55(6):817-825. doi: 10.1515/cclm-2016-1183.

PMID:
28222020
11.

French law: what about a reasoned reimbursement of serum vitamin D assays?

Souberbielle JC, Benhamou CL, Cortet B, Rousière M, Roux C, Abitbol V, Annweiler C, Audran M, Bacchetta J, Bataille P, Beauchet O, Bardet R, Benachi A, Berenbaum F, Blain H, Borson-Chazot F, Breuil V, Briot K, Brunet P, Carel JC, Caron P, Chabre O, Chanson P, Chapurlat R, Cochat P, Coutant R, Christin-Maitre S, Cohen-Solal M, Combe C, Cormier C, Courbebaisse M, Debrus G, Delemer B, Deschenes G, Duquenne M, Duval G, Fardellone P, Fouque D, Friedlander G, Gauvain JB, Groussin L, Guggenbuhl P, Houillier P, Hannedouche T, Jacot W, Javier RM, Jean G, Jeandel C, Joly D, Kamenicky P, Knebelmann B, Lafage-Proust MH, LeBouc Y, Legrand E, Levy-Weil F, Linglart A, Machet L, Maheu E, Mallet E, Marcelli C, Marès P, Mariat C, Maruani G, Maugars Y, Montagnon F, Moulin B, Orcel P, Partouche H, Personne V, Pierrot-Deseilligny C, Polak M, Pouteil-Noble C, Prié D, Raynaud-Simon A, Rolland Y, Sadoul JL, Salle B, Sault C, Schott AM, Sermet-Gaudelus I, Soubrier M, Tack I, Thervet E, Tostivint I, Touraine P, Tremollières F, Urena-Torres P, Viard JP, Wemeau JL, Weryha G, Winer N, Young J, Thomas T.

Geriatr Psychol Neuropsychiatr Vieil. 2016 Dec 1;14(4):377-382. Review.

PMID:
27818369
12.

Carboxy-terminal fragment of fibroblast growth factor 23 induces heart hypertrophy in sickle cell disease.

Courbebaisse M, Mehel H, Petit-Hoang C, Ribeil JA, Sabbah L, Tuloup-Minguez V, Bergerat D, Arlet JB, Stanislas A, Souberbielle JC, Le Clésiau H, Fischmeister R, Friedlander G, Prié D.

Haematologica. 2017 Feb;102(2):e33-e35. doi: 10.3324/haematol.2016.150987. Epub 2016 Oct 27. No abstract available.

13.

[Biomarkers of vascular calcifications: what are analytical limits to apply "research-grade" diagnostic kits into daily practice?].

Bargnoux AS, Arnaud J, Cavalier É, Piéroni L, Kamel S, Prié D, Souberbielle JC, Liabeuf S, Cristol JP; Groupe de Travail Mixte SFBC SN Biomarqueurs des Calcifications Vasculaires Au Cours de L'insuffisance Rénale Chronique.

Ann Biol Clin (Paris). 2015 May-Jun;73(3):323-32. doi: 10.1684/abc.2015.1043. Review. French.

14.

[The couple fibroblast growth factor 23 (FGF23)/Klotho].

Prié D; Groupe de Travail Mixte SFBC SN Biomarqueurs des Calcifications Vasculaires Au Cours de L'insuffisance Rénale Chronique.

Ann Biol Clin (Paris). 2015 May-Jun;73(3):299-304. doi: 10.1684/abc.2015.1048. French.

15.

Familial renal glycosuria and modifications of glucose renal excretion.

Prié D.

Diabetes Metab. 2014 Dec;40(6 Suppl 1):S12-6. doi: 10.1016/S1262-3636(14)72690-4.

PMID:
25554066
17.

Proteinuria Increases Plasma Phosphate by Altering Its Tubular Handling.

de Seigneux S, Courbebaisse M, Rutkowski JM, Wilhelm-Bals A, Metzger M, Khodo SN, Hasler U, Chehade H, Dizin E, Daryadel A, Stengel B; NephroTest Study Group, Girardin E, Prié D, Wagner CA, Scherer PE, Martin PY, Houillier P, Feraille E.

J Am Soc Nephrol. 2015 Jul;26(7):1608-18. doi: 10.1681/ASN.2014010104. Epub 2014 Oct 27.

18.

[Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement].

Souberbielle JC, Benhamou CL, Cortet B, Rousière M, Roux C, Abitbol V, Annweiler C, Audran M, Bacchetta J, Bataille P, Beauchet O, Bardet R, Benachi A, Berenbaum F, Blain H, Borson-Chazot F, Breuil V, Briot K, Brunet P, Carel JC, Caron P, Chabre O, Chanson P, Chapurlat R, Cochat P, Coutant R, Christin-Maitre S, Cohen-Solal M, Combe C, Cormier C, Courbebaisse M, Debrus G, Delemer B, Deschenes G, Duquenne M, Fardellone P, Fouque D, Friedlander G, Gauvain JB, Groussin L, Guggenbuhl P, Houillier P, Hannedouche T, Jacot W, Javier RM, Jean G, Jeandel C, Joly D, Kamenicky P, Knebelmann B, Lafage-Proust MH, LeBouc Y, Legrand E, Levy-Weil F, Linglart A, Machet L, Maheu E, Mallet E, Marcelli C, Marès P, Mariat C, Maruani G, Maugars Y, Montagnon F, Moulin B, Orcel P, Partouche H, Personne V, Pierrot-Deseilligny C, Polak M, Pouteil-Noble C, Prié D, Raynaud-Simon A, Rolland Y, Sadoul JL, Salle B, Sault C, Schott AM, Sermet-Gaudelus I, Soubrier M, Tack I, Thervet É, Tostivint I, Touraine P, Tremollières F, Urena-Torres P, Viard JP, Wemeau JL, Weryha G, Winer N, Young J, Thomas T.

Ann Biol Clin (Paris). 2014 Jul-Aug;72(4):385-9. doi: 10.1684/abc.2014.0972. French. No abstract available.

20.

Therapeutic management of hypophosphatemic rickets from infancy to adulthood.

Linglart A, Biosse-Duplan M, Briot K, Chaussain C, Esterle L, Guillaume-Czitrom S, Kamenicky P, Nevoux J, Prié D, Rothenbuhler A, Wicart P, Harvengt P.

Endocr Connect. 2014 Mar 14;3(1):R13-30. doi: 10.1530/EC-13-0103. Print 2014.

21.

[HAS report on vitamin D measurement: don't go from an extreme situation to another as extreme situation].

Souberbielle JC, Benhamou CL, Cortet B, Rousière M, Roux C, Abitbol V, Audran M, Bachetta J, Beauchet O, Blain H, Breuil V, Briot K, Brunet P, Chanson P, Cormier C, Courbebaisse M, Fardellone P, Fouque D, Friedlander G, Gauvain JB, Groussin L, Houillier P, Jacot W, Jean G, Kamenicky P, Lafage-Proust MH, Legrand E, Levy-Weil F, Linglart A, Mallet E, Marcelli C, Maruani G, Montagnon F, Personne V, Prié D, Raynaud-Simon A, Rolland Y, Salle B, Sault C, Schott AM, Thervet E, Urena-Torres P, Viard JP, Weryha G, Pierrot-Deseilligny C, Young J, Thomas T.

Presse Med. 2014 Jan;43(1):5-8. doi: 10.1016/j.lpm.2013.12.005. French. No abstract available.

PMID:
24439118
22.

Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations.

Francoz C, Nadim MK, Baron A, Prié D, Antoine C, Belghiti J, Valla D, Moreau R, Durand F.

Hepatology. 2014 Apr;59(4):1514-21. doi: 10.1002/hep.26704. Epub 2014 Mar 3.

PMID:
24037821
23.

Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list.

Prié D, Forand A, Francoz C, Elie C, Cohen I, Courbebaisse M, Eladari D, Lebrec D, Durand F, Friedlander G.

PLoS One. 2013 Jun 25;8(6):e66182. doi: 10.1371/journal.pone.0066182. Print 2013.

24.

Cinacalcet for cardiovascular disease in patients undergoing dialysis.

Urena-Torres P, Prié D, Souberbielle JC.

N Engl J Med. 2013 May 9;368(19):1842-3. doi: 10.1056/NEJMc1301247. No abstract available. Erratum in: N Engl J Med. 2013 Sep 5;369(10):986.

PMID:
23656654
25.

Reversible increase in FGF23 in a hypophosphatemic renal and bone disease linked to antiviral therapy by adefovir.

Ichchou L, Rist S, Lespessailles E, Prié D, Benhamou CL.

Joint Bone Spine. 2013 Dec;80(6):668-9. doi: 10.1016/j.jbspin.2013.02.014. Epub 2013 Apr 11. No abstract available.

PMID:
23583281
26.

Vitamin D status and outcomes after renal transplantation.

Bienaimé F, Girard D, Anglicheau D, Canaud G, Souberbielle JC, Kreis H, Noël LH, Friedlander G, Elie C, Legendre C, Prié D.

J Am Soc Nephrol. 2013 Apr;24(5):831-41. doi: 10.1681/ASN.2012060614. Epub 2013 Mar 28.

27.

Relationship between vitamin D deficiency and bone fragility in sickle cell disease: a cohort study of 56 adults.

Arlet JB, Courbebaisse M, Chatellier G, Eladari D, Souberbielle JC, Friedlander G, de Montalembert M, Prié D, Pouchot J, Ribeil JA.

Bone. 2013 Jan;52(1):206-11. doi: 10.1016/j.bone.2012.10.005. Epub 2012 Oct 13.

PMID:
23072921
28.

Determination of optimal cholecalciferol treatment in renal transplant recipients using a population pharmacokinetic approach.

Benaboud S, Urien S, Thervet E, Prié D, Legendre C, Souberbielle JC, Hirt D, Friedlander G, Treluyer JM, Courbebaisse M.

Eur J Clin Pharmacol. 2013 Mar;69(3):499-506. doi: 10.1007/s00228-012-1378-3. Epub 2012 Aug 31.

PMID:
22936122
29.

Determination of the best method to estimate glomerular filtration rate from serum creatinine in adult patients with sickle cell disease: a prospective observational cohort study.

Arlet JB, Ribeil JA, Chatellier G, Eladari D, De Seigneux S, Souberbielle JC, Friedlander G, de Montalembert M, Pouchot J, Prié D, Courbebaisse M.

BMC Nephrol. 2012 Aug 6;13:83. doi: 10.1186/1471-2369-13-83.

30.

Functional interaction between CFTR and the sodium-phosphate co-transport type 2a in Xenopus laevis oocytes.

Bakouh N, Chérif-Zahar B, Hulin P, Prié D, Friedlander G, Edelman A, Planelles G.

PLoS One. 2012;7(4):e34879. doi: 10.1371/journal.pone.0034879. Epub 2012 Apr 13.

31.

A new human NHERF1 mutation decreases renal phosphate transporter NPT2a expression by a PTH-independent mechanism.

Courbebaisse M, Leroy C, Bakouh N, Salaün C, Beck L, Grandchamp B, Planelles G, Hall RA, Friedlander G, Prié D.

PLoS One. 2012;7(4):e34764. doi: 10.1371/journal.pone.0034764. Epub 2012 Apr 10.

32.

Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria?

Kamenický P, Blanchard A, Gauci C, Salenave S, Letierce A, Lombès M, Brailly-Tabard S, Azizi M, Prié D, Souberbielle JC, Chanson P.

J Clin Endocrinol Metab. 2012 Jun;97(6):2124-33. doi: 10.1210/jc.2011-3188. Epub 2012 Apr 10.

PMID:
22496496
33.

Effects of cinacalcet in renal transplant patients with hyperparathyroidism.

Courbebaisse M, Diet C, Timsit MO, Mamzer MF, Thervet E, Noel LH, Legendre C, Friedlander G, Martinez F, Prié D.

Am J Nephrol. 2012;35(4):341-8. doi: 10.1159/000337526. Epub 2012 Mar 30.

PMID:
22473131
34.

A functional allelic variant of the FGF23 gene is associated with renal phosphate leak in calcium nephrolithiasis.

Rendina D, Esposito T, Mossetti G, De Filippo G, Gianfrancesco F, Perfetti A, Magliocca S, Formisano P, Prié D, Strazzullo P.

J Clin Endocrinol Metab. 2012 May;97(5):E840-4. doi: 10.1210/jc.2011-1528. Epub 2012 Mar 14.

PMID:
22419710
35.

[Hyperuricemia in sickle cell disease in France].

Arlet JB, Ribeil JA, Chatellier G, Pouchot J, de Montalembert M, Prié D, Courbebaisse M.

Rev Med Interne. 2012 Jan;33(1):13-7. doi: 10.1016/j.revmed.2011.07.002. Epub 2011 Sep 9. French.

PMID:
21907467
36.

Phosphate handling: new genes, new molecules.

Prié D, Torres PU, Friedlander G.

Horm Res Paediatr. 2011;76 Suppl 1:71-5. doi: 10.1159/000329175. Epub 2011 Jul 21. Review.

PMID:
21778753
37.

Vitamin D metabolism and activity in the parathyroid gland.

Bienaimé F, Prié D, Friedlander G, Souberbielle JC.

Mol Cell Endocrinol. 2011 Dec 5;347(1-2):30-41. doi: 10.1016/j.mce.2011.05.031. Epub 2011 Jun 1. Review.

PMID:
21664247
38.

Normal plasma FGF23 levels kinetic in tenofovir-related hypophosphatemic osteomalacia in an HIV-infected patient with von Recklinghausen disease.

Saidenberg-Kermanac'h N, Souabni L, Prendki V, Prie D, Boissier MC.

Joint Bone Spine. 2011 May;78(3):306-8. doi: 10.1016/j.jbspin.2010.11.007. Epub 2010 Dec 23.

PMID:
21185214
39.

Cholecalciferol supplementation does not protect against renal allograft structural and functional deterioration: a retrospective study.

Courbebaisse M, Xu-Dubois YC, Thervet E, Prié D, Zuber J, Kreis H, Legendre C, Rondeau E, Pallet N.

Transplantation. 2011 Jan 27;91(2):207-12. doi: 10.1097/TP.0b013e318200ba37.

PMID:
21131899
40.

Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score.

Francoz C, Prié D, Abdelrazek W, Moreau R, Mandot A, Belghiti J, Valla D, Durand F.

Liver Transpl. 2010 Oct;16(10):1169-77. doi: 10.1002/lt.22128.

41.

Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.

Prié D, Friedlander G.

Clin J Am Soc Nephrol. 2010 Sep;5(9):1717-22. doi: 10.2215/CJN.02680310. Epub 2010 Aug 26. Review.

42.

Genetic disorders of renal phosphate transport.

Prié D, Friedlander G.

N Engl J Med. 2010 Jun 24;362(25):2399-409. doi: 10.1056/NEJMra0904186. Review. No abstract available.

PMID:
20573928
43.

[Non phosphocalcic actions of vitamin D].

Courbebaisse M, Souberbielle JC, Prié D, Thervet E.

Med Sci (Paris). 2010 Apr;26(4):417-21. doi: 10.1051/medsci/2010264417. Review. French.

44.

The phosphate transporter PiT1 (Slc20a1) revealed as a new essential gene for mouse liver development.

Beck L, Leroy C, Beck-Cormier S, Forand A, Salaün C, Paris N, Bernier A, Ureña-Torres P, Prié D, Ollero M, Coulombel L, Friedlander G.

PLoS One. 2010 Feb 10;5(2):e9148. doi: 10.1371/journal.pone.0009148.

45.

Urinary procollagen III aminoterminal propeptide (PIIINP): a fibrotest for the nephrologist.

Ghoul BE, Squalli T, Servais A, Elie C, Meas-Yedid V, Trivint C, Vanmassenhove J, Grünfeld JP, Olivo-Marin JC, Thervet E, Noël LH, Prié D, Fakhouri F.

Clin J Am Soc Nephrol. 2010 Feb;5(2):205-10. doi: 10.2215/CJN.06610909. Epub 2010 Jan 14.

46.

[Fibroblast Growth Factor 23-Klotho: a new axis of phosphate balance control].

Prié D, Ureña Torres P, Friedlander G.

Med Sci (Paris). 2009 May;25(5):489-95. doi: 10.1051/medsci/2009255489. Review. French.

47.

[A new axis of phosphate balance control: fibroblast growth factor 23-Klotho].

Prié D, Torres PU, Friedlander G.

Nephrol Ther. 2009 Nov;5(6):513-9. doi: 10.1016/j.nephro.2009.04.001. Epub 2009 May 22. Review. French.

PMID:
19464978
48.

Molecular analyte profiling of the early events and tissue conditioning following intravesical bacillus calmette-guerin therapy in patients with superficial bladder cancer.

Bisiaux A, Thiounn N, Timsit MO, Eladaoui A, Chang HH, Mapes J, Mogenet A, Bresson JL, Prié D, Béchet S, Baron C, Sadorge C, Thomas S, Albert EB, Albert PS, Albert ML.

J Urol. 2009 Apr;181(4):1571-80. doi: 10.1016/j.juro.2008.11.124. Epub 2009 Feb 23.

PMID:
19230924
49.

Latest findings in phosphate homeostasis.

Prié D, Ureña Torres P, Friedlander G.

Kidney Int. 2009 May;75(9):882-9. doi: 10.1038/ki.2008.643. Epub 2009 Feb 4. Review.

50.

Klotho gene, phosphocalcic metabolism, and survival in dialysis.

Torres PU, Prié D, Beck L, De Brauwere D, Leroy C, Friedlander G.

J Ren Nutr. 2009 Jan;19(1):50-6. doi: 10.1053/j.jrn.2008.10.018. Review.

PMID:
19121771

Supplemental Content

Support Center